WCM
TWST icon

Weld Capital Management’s Twist Bioscience TWST Stock Holding History

Weld Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,714
Closed -$242K – 552
2020
Q4 		$242K Sell
1,714
-2,134
-55% -$237K 0.1% 341
2020
Q3 		$292K Buy
+3,848
New +$240K 0.12% 295

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Weld Capital Management's TWST Position: Q1 2021 in Review

Weld Capital Management sold out of Twist Bioscience (TWST) in Q1 2021, closing a stake of 1,714 shares — an estimated $242K sold.

Weld Capital Management first reported a position in TWST in Q3 2020 and held it in 2 quarters. The position peaked at $292K in Q3 2020. 239 funds tracked by Wall St. Rank hold TWST as of Q1 2021.

  • Weld Capital Management reported no remaining Twist Bioscience position as of Q1 2021 after selling out during the quarter.
  • Weld Capital Management sold 1,714 Twist Bioscience shares in Q1 2021, an estimated $242K.
  • Weld Capital Management first reported a position in Twist Bioscience in Q3 2020 and held it in 2 quarters.
  • Weld Capital Management's Twist Bioscience position peaked at $292K in Q3 2020.
  • 239 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2021.

Based on Weld Capital Management's 13F filing for Q1 2021, filed 17 May 2021.